| Dr Michael Stephen Guy, MD | |
|
3700 Southern Blvd Ste 201, Kettering, OH 45429-1265 | |
| (855) 500-2873 | |
| (937) 281-3992 |
| Full Name | Dr Michael Stephen Guy |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 16 Years |
| Location | 3700 Southern Blvd Ste 201, Kettering, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174773287 | NPI | - | NPPES |
| 0138338 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35.125746 (Ohio) | Secondary |
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 35.125746 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Kettering Medical Center | Kettering, OH | Hospital |
| Grandview And Southview Hospitals | Dayton, OH | Hospital |
| Upper Valley Medical Center | Troy, OH | Hospital |
| Atrium Medical Center | Franklin, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kettering Independent Medical Group Inc | 3173710936 | 586 |
| Premier Health Specialists Inc | 5597708594 | 394 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
| Entity Name | Alliance Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437125572 PECOS PAC ID: 0840104360 Enrollment ID: O20031118000529 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
| Entity Name | Premier Health Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194958223 PECOS PAC ID: 5597708594 Enrollment ID: O20050610000010 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
| Entity Name | Kettering Independent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629387865 PECOS PAC ID: 3173710936 Enrollment ID: O20101207000425 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Stephen Guy, MD 3700 Southern Blvd Ste 201, Kettering, OH 45429-1265 Ph: (855) 500-2873 | Dr Michael Stephen Guy, MD 3700 Southern Blvd Ste 201, Kettering, OH 45429-1265 Ph: (855) 500-2873 |
News Archive
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.
› Verified 9 days ago
Cathy E Liesner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3533 Southern Blvd, Ste 4600, Kettering, OH 45449 Phone: 937-296-0167 Fax: 937-297-2330 | |
Helen K Mirau, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 215 E Stroop Rd, Suite 204, Kettering, OH 45429 Phone: 937-293-3680 Fax: 937-293-3698 | |
V. Joseph Karnitis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3533 Southern Blvd, Suite 4100, Kettering, OH 45429 Phone: 937-395-8444 Fax: 937-395-8450 | |
Sunita M Reddy, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3533 Southern Blvd, Ste 4600, Kettering, OH 45429 Phone: 937-296-0167 Fax: 937-297-2330 | |
Marcia L Collins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3533 Southern Blvd, Ste 4600, Kettering, OH 45429 Phone: 937-296-0167 Fax: 937-297-2330 | |
Najwa Tabrah, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3533 Southern Blvd, Suite 4600, Kettering, OH 45429 Phone: 937-296-0167 Fax: 937-297-2330 |